<DOC>
	<DOCNO>NCT00167791</DOCNO>
	<brief_summary>This study patient high risk kidney rejection kidney transplant . The hypothesis treatment medication call rituximab make possible receive kidney transplant donor previously present good match .</brief_summary>
	<brief_title>Rituximab Desensitization Therapy Patients Waiting List Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Active status kidney transplant wait list positive cross match live donor Receipt live vaccine within 4 week prior randomization Previous Treatment Rituximab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>transplant</keyword>
	<keyword>desensitization</keyword>
	<keyword>kidney transplant</keyword>
</DOC>